12:00 AM
May 21, 2012
 |  BC Week In Review  |  Company News  |  Other News

Fibrocell dermatology, neurology news

Fibrocell announced the formation of the Clinical Investigations for Dermal Mesenchymally-Obtained Derivatives (CIDMOD) Initiative to translate human skin cell derivatives into patient-specific cellular therapies for cosmetic, regenerative and general therapeutic...

Read the full 127 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >